8-K/A filed September 26, 2023, 7:59 PM ET ticker ERNA CIK 0000748592

leadership confidence high sentiment neutral materiality 0.15

Dorothy J. Clarke appointed to all three committees of Eterna Therapeutics Board

Ernexa Therapeutics Inc.

Dorothy J. Clarke appointed to Audit Committee, Compensation Committee, and Nominating and Governance Committee.
Appointment effective September 23, 2023; committee roles are immediate.
Clarke joined the Board on August 28, 2023, for term through 2024 annual meeting.

item 5.02

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-045249

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.